Effect of Emotional Freedom Technique on Symptoms in Dysmenorrhea

May 10, 2024 updated by: Ayse Cuvadar, Karabuk University

Examining the Effect of Emotional Freedom Technique on Quality of Life and Symptoms in Dysmenorrhea

  1. Reducing symptoms with EFT in young women suffering from dysmenorrhea
  2. Improving the quality of life of young women suffering from dysmenorrhea
  3. Raising women's awareness for EFT
  4. Reducing healthcare costs for dysmenorrhea

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Primary dysmenorrhea, the most common form of dysmenorrhea, is a problem characterized by pain that begins in the lower abdomen before or with menstruation, lower back pain and pain radiating to the legs. The Emotion Freedom Techniqu has become a manualized method that has led to uniform application research, education, and clinical practice. EFT is a brief intervention that combines exposure, cognitive therapy, and somatic stimulation of acupressure points on the face and body. It has been reported in the literature that EFT, a "needle-free and emotional" form of acupuncture, reduces or eliminates dysmenorrhea symptoms and premenstrual complaints.

Study Type

Interventional

Enrollment (Actual)

65

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Karabuk, Turkey, 78050
        • Karabuk University
    • Karabuk
      • Karabük, Karabuk, Turkey, 78050
        • Karabuk University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • • Being a female student at Karabük University Faculty of Health Sciences

    • Being between the ages of 18-25
    • Voluntarily agrees to participate in the study,
    • T.R. to be a citizen,
    • Not having any chronic disease,
    • Those whose symptom complaints are 5 or above according to the VAS scale

Exclusion Criteria:

  • • Leaving the study at any time,

    • Having any diagnosed psychiatric disorder.
    • Not having secondary dysmenorrhea pathology

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: İntervention (EFT) group

In order to determine the students who meet our study criteria, PİF, DDF, VAS, MSS and Short Form 36 will be applied for the pre-test to female students studying in the relevant departments of KBÜ SBF.

To EFT Group; After the first tests are done, the 1st EFT session will be held, the 2nd EFT session will be held 30 days later, and the final tests will be done 30 days later. During this period, affirmations will be given depending on the need. Each session is planned to last an average of 45 minutes - 1 hour, and duration and affirmations will be arranged according to the woman's individual difficulties, perspective, support systems, past traumas and emotional blockages.

4th Procedure: Preliminary tests will be carried out and then the 1st EFT session will be held.

5. Procedure: After 30 days, the first final tests will be performed and then the second EFT session will be held.

Procedure 6: After 30 days, only the 2nd final tests will be performed.

Preliminary tests will be carried out and then the 1st EFT session will be held.

After 30 days, the first final tests will be performed and then the second EFT session will be held.

After 30 days, only the 2nd final tests will be performed.

No Intervention: Control group

In order to determine the students who meet our study criteria, PİF, DDF, VAS, MSS and Short Form 36 will be applied for the pre-test to female students studying in the relevant departments of KBÜ SBF. Students in the control group will receive routine counseling regarding primary dysmenorrhea, and no extra intervention or practice will be performed.

Procedure 1: Preliminary tests will be conducted and then general training for dysmenorrhea will be conducted.

2nd Process: 30 days later, the questions of the students who will take the 1st post-test will be answered.

3rd Procedure: After 30 days, the second final tests will be performed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Examining the Effect of Emotional Freedom Technique on Quality of Life and Symptoms in Dysmenorrhea
Time Frame: Preliminary tests will be carried out and then the 1st EFT session will be held. After 30 days, the first final tests will be performed and then the second EFT session will be held. After 30 days, only the 2nd final tests will be performed.
Emotional Freedom Technique
Preliminary tests will be carried out and then the 1st EFT session will be held. After 30 days, the first final tests will be performed and then the second EFT session will be held. After 30 days, only the 2nd final tests will be performed.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Actual)

April 15, 2024

Study Completion (Actual)

May 10, 2024

Study Registration Dates

First Submitted

November 4, 2023

First Submitted That Met QC Criteria

November 8, 2023

First Posted (Actual)

November 13, 2023

Study Record Updates

Last Update Posted (Actual)

May 13, 2024

Last Update Submitted That Met QC Criteria

May 10, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • E-77192459-050.99-232650

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on EFT group

Subscribe